Long - Term Cardiomyopathy Risk Varies by Chemo Agent

Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Cardiology, Oncology, Pediatrics, Pharmacy, Journal, Source Type: news